These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


163 related items for PubMed ID: 657285

  • 21. AKR mouse leukemic cells in tissue culture. II. Immunologic studies on the AKR 87 cell line.
    Duś D, Harlozińska A, Skriabin A, Richter R.
    Arch Immunol Ther Exp (Warsz); 1976; 24(5):727-40. PubMed ID: 187141
    [Abstract] [Full Text] [Related]

  • 22. Murine leukemia virus-associated cell surface antigens in rats neonatally infected with Gross murine leukemia virus.
    Basch RS, Grausz D, Harris N, Mitchison NA.
    J Natl Cancer Inst; 1979 Dec; 63(6):1485-92. PubMed ID: 292817
    [Abstract] [Full Text] [Related]

  • 23. Alteration of skin in gross leukemia. V. Refutation of virus involvement.
    Mariani T, Maruyama Y.
    J Natl Cancer Inst; 1974 Dec; 53(6):1661-4. PubMed ID: 4612164
    [No Abstract] [Full Text] [Related]

  • 24. Production of migration inhibition factor by spleen cells of normal rats upon culture in vitro with tumor cells and cells expressing endogenous virus.
    Sharma JM, Herberman RB, Djeu JY, Nunn ME.
    J Immunol; 1979 Jul; 123(1):222-31. PubMed ID: 221590
    [No Abstract] [Full Text] [Related]

  • 25. [Expression of an antigen associated with Gross virus on the surfaces of murine cells producing an oncornavirus from the radioleukemia of C57BL/6 mice].
    Gerlier D, Guillemain B, Doré JF, Duplan JF.
    C R Acad Hebd Seances Acad Sci D; 1977 Jun 20; 284(23):2431-4. PubMed ID: 198153
    [Abstract] [Full Text] [Related]

  • 26. T cells from naive mice suppress the in vitro cytotoxic response against endogenous Gross virus-induced tumor cells.
    Tilkin AF, Gomard E, Begue B, Levy JP.
    J Immunol; 1984 Jan 20; 132(1):520-6. PubMed ID: 6228582
    [Abstract] [Full Text] [Related]

  • 27. Induction of anti-AKR/gross virus cytolytic T lymphocytes in AKR.H-2b:Fv-1b congenic mice: age-dependent conversion to a nonresponder phenotype.
    Green WR.
    J Immunol; 1987 Mar 01; 138(5):1602-6. PubMed ID: 3027182
    [Abstract] [Full Text] [Related]

  • 28. Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: studies on cell-mediated immunity and humoral antibody response.
    Mantovani A, Spreafico F.
    Eur J Cancer (1965); 1975 Aug 01; 11(8):537-44. PubMed ID: 1222761
    [No Abstract] [Full Text] [Related]

  • 29. Immune response to Gross virus-induced lymphoma. 3. Characteristics of the cellular immune response.
    De Landazuri MO, Herberman RB.
    J Natl Cancer Inst; 1972 Jul 01; 49(1):147-54. PubMed ID: 5037432
    [No Abstract] [Full Text] [Related]

  • 30. Viral and cellular surface antigens of murine leukemias and myelomas. Serological analysis by immunoelectron microscopy.
    Aoki T, Takahashi T.
    J Exp Med; 1972 Mar 01; 135(3):443-57. PubMed ID: 5058232
    [Abstract] [Full Text] [Related]

  • 31. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR.
    J Immunol; 1980 Dec 01; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract] [Full Text] [Related]

  • 32. Solubilization of G (gross) antigens on the surface of G leukemia cells.
    Herberman RB, Aoki T, Nunn ME.
    J Natl Cancer Inst; 1973 Feb 01; 50(2):481-90. PubMed ID: 4702119
    [No Abstract] [Full Text] [Related]

  • 33. Serologic and immunochemical studies of the cell membrane alloantigens of K36, an AKR spontaneous leukemia.
    Schmidt W, Festenstein H, Atfield G.
    Transplant Proc; 1980 Mar 01; 12(1):29-31. PubMed ID: 7368291
    [No Abstract] [Full Text] [Related]

  • 34. Participation of three lymphoid cell types in the in vitro activation of cell-mediated immunity to a syngeneic gross virus-induced lymphoma in rats.
    Djeu JY, Glaser M, Huang KY, Herberman RB.
    Cell Immunol; 1976 May 01; 23(2):268-77. PubMed ID: 1084228
    [No Abstract] [Full Text] [Related]

  • 35. Antibody-dependent cellular cytotoxicity to a syngeneic Gross virus-induced lymphoma.
    Ortiz de Landazuri M, Kedar E, Fahey JL.
    J Natl Cancer Inst; 1974 Jan 01; 52(1):147-52. PubMed ID: 4204244
    [No Abstract] [Full Text] [Related]

  • 36. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R, Graziano RF, Green WR.
    J Immunol; 1986 Mar 15; 136(6):2271-9. PubMed ID: 3005407
    [Abstract] [Full Text] [Related]

  • 37. In vitro depression of cellular immunity by Friend virus leukemic spleen cells.
    Toy ST, Whellock EF.
    Cell Immunol; 1975 May 15; 17(1):57-73. PubMed ID: 1168547
    [No Abstract] [Full Text] [Related]

  • 38. Mechanism of nonresponsiveness to AKR/Gross leukemia virus in AKR.H-2b:Fv-1b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice.
    Wegmann KW, McMaster JS, Green WR.
    J Immunol; 1991 Apr 01; 146(7):2469-77. PubMed ID: 2005406
    [Abstract] [Full Text] [Related]

  • 39. G(AKSL2): a new cell surface antigen of the mouse related to the dualtropic mink cell focus-inducing class of murine leukemia virus detected by naturally occurring antibody.
    Stockert E, DeLeo AB, O'Donnell PV, Obata Y, Old LJ.
    J Exp Med; 1979 Jan 01; 149(1):200-15. PubMed ID: 216764
    [Abstract] [Full Text] [Related]

  • 40. Cell-surface and virion-envelope antigens shared by radiation leukemia virus (RadLV) and other murine c-type viruses.
    Ferrer JF.
    Int J Cancer; 1973 Sep 15; 12(2):378-88. PubMed ID: 4134124
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.